Literature DB >> 19807154

Endogenous levels of Echinacea alkylamides and ketones are important contributors to the inhibition of prostaglandin E2 and nitric oxide production in cultured macrophages.

Carlie A LaLone1, Ludmila Rizshsky, Kimberly D P Hammer, Lankun Wu, Avery K S Solco, Manyu Yum, Basil J Nikolau, Eve S Wurtele, Patricia A Murphy, Meehye Kim, Diane F Birt.   

Abstract

Because of the popularity of Echinacea as a dietary supplement, researchers have been actively investigating which Echinacea constituent or groups of constituents are necessary for immune-modulating bioactivities. Our prior studies indicate that alkylamides may play an important role in the inhibition of prostaglandin E2 (PGE(2)) production. High-performance liquid chromatography fractionation, employed to elucidate interacting anti-inflammatory constituents from ethanol extracts of Echinacea purpurea, Echinacea angustifolia, Echinacea pallida, and Echinacea tennesseensis, identified fractions containing alkylamides and ketones as key anti-inflammatory contributors using lipopolysaccharide-induced PGE(2) production in RAW264.7 mouse macrophage cells. Nitric oxide (NO) production and parallel cytotoxicity screens were also employed to substantiate an anti-inflammatory response. E. pallida showed significant inhibition of PGE(2) with a first round fraction, containing gas chromatography-mass spectrometry (GC-MS) peaks for Bauer ketones 20, 21, 22, 23, and 24, with 23 and 24 identified as significant contributors to this PGE(2) inhibition. Chemically synthesized Bauer ketones 21 and 23 at 1 microM each significantly inhibited both PGE(2) and NO production. Three rounds of fractionation were produced from an E. angustifolia extract. GC-MS analysis identified the presence of Bauer ketone 23 in third round fraction 3D32 and Bauer alkylamide 11 making up 96% of third round fraction 3E40. Synthetic Bauer ketone 23 inhibited PGE(2) production to 83% of control, and synthetic Bauer alkylamide 11 significantly inhibited PGE(2) and NO production at the endogenous concentrations determined to be present in their respective fraction; thus, each constituent partially explained the in vitro anti-inflammatory activity of their respective fraction. From this study, two key contributors to the anti-inflammatory properties of E. angustifolia were identified as Bauer alkylamide 11 and Bauer ketone 23.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19807154      PMCID: PMC2777644          DOI: 10.1021/jf901202y

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  23 in total

1.  HPLC method validated for the simultaneous analysis of cichoric acid and alkamides in Echinacea purpurea plants and products.

Authors:  Per Mølgaard; Søren Johnsen; Peter Christensen; Claus Cornett
Journal:  J Agric Food Chem       Date:  2003-11-19       Impact factor: 5.279

2.  Inhibition of NF-kappaB activation and expression of inflammatory mediators by polyacetylene spiroketals from Plagius flosculosus.

Authors:  Marco A Calzado; Katharina Schmid Lüdi; Bernd Fiebich; Yinon Ben-Neriah; Susanne Bacher; Eduardo Munoz; Mauro Ballero; Simona Prosperini; Giovanni Appendino; M Lienhard Schmitz
Journal:  Biochim Biophys Acta       Date:  2005-06-30

3.  Alkamide stability in Echinacea purpurea extracts with and without phenolic acids in dry films and in solution.

Authors:  Yi Liu; Patricia A Murphy
Journal:  J Agric Food Chem       Date:  2007-01-10       Impact factor: 5.279

4.  Macrophage activating effects of new alkamides from the roots of Echinacea species.

Authors:  Ying Chen; Tong Fu; Tao Tao; Jinghua Yang; Yung Chang; Meihua Wang; Linda Kim; Luping Qu; John Cassady; Ric Scalzo; Xiping Wang
Journal:  J Nat Prod       Date:  2005-05       Impact factor: 4.050

5.  Effect of temperature on stability of marker constituents in Echinacea purpurea root formulations.

Authors:  J Livesey; D V Awang; J T Arnason; W Letchamo; M Barrett; G Pennyroyal
Journal:  Phytomedicine       Date:  1999-11       Impact factor: 5.340

6.  The effect of seed source, light during germination, and cold-moist stratification on seed germination in three species of Echinacea for organic production.

Authors:  Fredy R Romero; Kathleen Delate; David J Hannapel
Journal:  HortScience       Date:  2005-10       Impact factor: 1.455

Review 7.  Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.

Authors:  Joanne Barnes; Linda A Anderson; Simon Gibbons; J David Phillipson
Journal:  J Pharm Pharmacol       Date:  2005-08       Impact factor: 3.765

8.  P-Glycoprotein inhibitory activity of lipophilic constituents of Echinacea pallida roots in a human proximal tubular cell line.

Authors:  Nadia Romiti; Federica Pellati; Paola Nieri; Stefania Benvenuti; Barbara Adinolfi; Elisabetta Chieli
Journal:  Planta Med       Date:  2008-02       Impact factor: 3.352

9.  Alkamides from Echinacea inhibit cyclooxygenase-2 activity in human neuroglioma cells.

Authors:  Burkhard Hinz; Karin Woelkart; Rudolf Bauer
Journal:  Biochem Biophys Res Commun       Date:  2007-06-19       Impact factor: 3.575

10.  Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation.

Authors:  Zili Zhai; Avery Solco; Lankun Wu; Eve S Wurtele; Marian L Kohut; Patricia A Murphy; Joan E Cunnick
Journal:  J Ethnopharmacol       Date:  2008-12-07       Impact factor: 4.360

View more
  8 in total

1.  Enrichment of Echinacea angustifolia with Bauer alkylamide 11 and Bauer ketone 23 increased anti-inflammatory potential through interference with cox-2 enzyme activity.

Authors:  Carlie A Lalone; Nan Huang; Ludmila Rizshsky; Man-Yu Yum; Navrozedeep Singh; Cathy Hauck; Basil J Nikolau; Eve S Wurtele; Marian L Kohut; Patricia A Murphy; Diane F Birt
Journal:  J Agric Food Chem       Date:  2010-08-11       Impact factor: 5.279

2.  Bauer ketones 23 and 24 from Echinacea paradoxa var. paradoxa inhibit lipopolysaccharide-induced nitric oxide, prostaglandin E2 and cytokines in RAW264.7 mouse macrophages.

Authors:  Xiaozhu Zhang; Ludmila Rizshsky; Catherine Hauck; Luping Qu; Mark P Widrlechner; Basil J Nikolau; Patricia A Murphy; Diane F Birt
Journal:  Phytochemistry       Date:  2011-11-29       Impact factor: 4.072

3.  Echinacea purpurea (L.) Moench modulates human T-cell cytokine response.

Authors:  Fabiana N Fonseca; Genovefa Papanicolaou; Hong Lin; Clara B S Lau; Edward J Kennelly; Barrie R Cassileth; Susanna Cunningham-Rundles
Journal:  Int Immunopharmacol       Date:  2014-01-13       Impact factor: 4.932

Review 4.  Echinacea for preventing and treating the common cold.

Authors:  Marlies Karsch-Völk; Bruce Barrett; David Kiefer; Rudolf Bauer; Karin Ardjomand-Woelkart; Klaus Linde
Journal:  Cochrane Database Syst Rev       Date:  2014-02-20

5.  Echinacea-induced cytosolic Ca2+ elevation in HEK293.

Authors:  Lankun Wu; Eric W Rowe; Ksenija Jeftinija; Srdija Jeftinija; Ludmila Rizshsky; Basil J Nikolau; Jodi McKay; Marian Kohut; Eve Syrkin Wurtele
Journal:  BMC Complement Altern Med       Date:  2010-11-23       Impact factor: 3.659

6.  Ethanolic Echinacea purpurea Extracts Contain a Mixture of Cytokine-Suppressive and Cytokine-Inducing Compounds, Including Some That Originate from Endophytic Bacteria.

Authors:  Daniel A Todd; Travis V Gulledge; Emily R Britton; Martina Oberhofer; Martha Leyte-Lugo; Ashley N Moody; Tatsiana Shymanovich; Laura F Grubbs; Monika Juzumaite; Tyler N Graf; Nicholas H Oberlies; Stanley H Faeth; Scott M Laster; Nadja B Cech
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

7.  The Anti-Inflammatory and Vasodilating Effects of Three Selected Dietary Organic Sulfur Compounds from Allium Species.

Authors:  Chin-Chen Chu; Wen-Shiann Wu; Ja-Ping Shieh; Heuy-Ling Chu; Chia-Pu Lee; Pin-Der Duh
Journal:  J Funct Biomater       Date:  2017-01-26

Review 8.  Herbal Medicines-Are They Effective and Safe during Pregnancy?

Authors:  Beata Sarecka-Hujar; Beata Szulc-Musioł
Journal:  Pharmaceutics       Date:  2022-01-12       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.